tyramine has been researched along with Myocardial Infarction in 15 studies
Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Tyramine (Tyr) was intravenously administered before 30 min ischaemia in the absence or presence of bunazosin (BN, alpha1-receptor blocker) and staurosporine (ST), a protein kinase C inhibitor, respectively." | 1.33 | Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits. ( Baba, K; Fujiwara, H; Kariya, T; Kawai, T; Minatoguchi, S; Takahashi, M; Takemura, G; Uno, Y; Zhang, C, 2005) |
| "Myocardial ischemia is associated with a pronounced increase of MIF catecholamines, which is at least in part mediated by a reversed neuronal reuptake mechanism." | 1.31 | Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo. ( Alberts, G; Boomsma, F; de Zeeuw, S; Duncker, DJ; Lameris, TW; van Den Meiracker, AH; Veld, AJ; Verdouw, PD, 2000) |
| "Tyramine pretreatment resulted in a smaller infarct size than in untreated controls (AN/AR, 0." | 1.29 | Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning. ( Bankwala, Z; Hale, SL; Kloner, RA, 1994) |
| "Adenosine receptors were blocked with 8-p-sulfophenyl theophylline (10 mg/kg intravenously), alpha 1-adrenergic receptors were selectively blocked with prazosin (0." | 1.29 | Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning. ( Chien, GL; Davis, RF; Haessler, R; Kuzume, K; Van Winkle, DM; Wolff, RA, 1996) |
| "Defibrotide is a polydeoxyribonucleotide of mammalian origin which possesses profibrinolytic effect and PGI2-releasing capacity." | 1.27 | Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit. ( Berti, F; Mandelli, C; Niada, R; Omini, C; Pretolani, M; Rossoni, G, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (40.00) | 18.7374 |
| 1990's | 5 (33.33) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 1 (6.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Niotis, AE | 1 |
| Mastichiadis, C | 1 |
| Petrou, PS | 1 |
| Christofidis, I | 1 |
| Kakabakos, SE | 1 |
| Siafaka-Kapadai, A | 1 |
| Misiakos, K | 1 |
| Baba, K | 1 |
| Minatoguchi, S | 1 |
| Zhang, C | 1 |
| Kariya, T | 1 |
| Uno, Y | 1 |
| Kawai, T | 1 |
| Takahashi, M | 1 |
| Takemura, G | 1 |
| Fujiwara, H | 1 |
| Parrish, DC | 1 |
| Gritman, K | 1 |
| Van Winkle, DM | 2 |
| Woodward, WR | 1 |
| Bader, M | 1 |
| Habecker, BA | 1 |
| Baumann, G | 1 |
| Felix, SB | 1 |
| Schrader, J | 1 |
| Heidecke, CD | 1 |
| Riess, G | 1 |
| Erhardt, WD | 1 |
| Ludwig, L | 1 |
| Loher, U | 1 |
| Sebening, F | 1 |
| Blömer, H | 1 |
| Downey, JM | 3 |
| Cohen, MV | 3 |
| Ytrehus, K | 1 |
| Liu, Y | 1 |
| Bankwala, Z | 1 |
| Hale, SL | 1 |
| Kloner, RA | 1 |
| Toombs, CF | 1 |
| Wiltse, AL | 1 |
| Shebuski, RJ | 1 |
| Haessler, R | 1 |
| Kuzume, K | 2 |
| Wolff, RA | 1 |
| Chien, GL | 1 |
| Davis, RF | 1 |
| Yang, XM | 1 |
| Lameris, TW | 1 |
| de Zeeuw, S | 1 |
| Alberts, G | 1 |
| Boomsma, F | 1 |
| Duncker, DJ | 1 |
| Verdouw, PD | 1 |
| Veld, AJ | 1 |
| van Den Meiracker, AH | 1 |
| Faraj, BA | 1 |
| Dayton, PG | 1 |
| Camp, VM | 1 |
| Wilson, JP | 1 |
| Malveaux, EF | 1 |
| Schlant, RC | 1 |
| Matsuki, T | 1 |
| Holt, G | 1 |
| Ayling, J | 1 |
| Hearse, DJ | 1 |
| Johnstone, DE | 1 |
| Janes, RD | 1 |
| Klassen, GA | 1 |
| Armour, JA | 1 |
| Berti, F | 1 |
| Rossoni, G | 1 |
| Niada, R | 1 |
| Omini, C | 1 |
| Pretolani, M | 1 |
| Mandelli, C | 1 |
| Vollenberger, A | 1 |
| Shakhab, L | 1 |
15 other studies available for tyramine and Myocardial Infarction
| Article | Year |
|---|---|
Dual-cardiac marker capillary waveguide fluoroimmunosensor based on tyramide signal amplification.
Topics: Animals; Antibodies; Biosensing Techniques; Calibration; Creatine Kinase, MB Form; Humans; Immunoass | 2010 |
Alpha1-receptor or adenosine A1-receptor dependent pathway alone is not sufficient but summation of these pathways is required to achieve an ischaemic preconditioning effect in rabbits.
Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adrenergic alpha-1 Rec | 2005 |
Postinfarct sympathetic hyperactivity differentially stimulates expression of tyrosine hydroxylase and norepinephrine transporter.
Topics: Adrenergic beta-Agonists; Angiotensinogen; Animals; Animals, Genetically Modified; Coronary Vessels; | 2008 |
Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Characterization of two new specific H2-receptor agonists, impromidine and dimaprit, in the guinea pig and human myocardium.
Topics: Adenylyl Cyclases; Animals; Cimetidine; Cyclic AMP; Dimaprit; Dose-Response Relationship, Drug; Fema | 1981 |
Cellular mechanisms in ischemic preconditioning: the role of adenosine and protein kinase C.
Topics: Adenosine; Animals; Blood Pressure; GTP-Binding Proteins; Myocardial Infarction; Myocardial Ischemia | 1994 |
Alpha-adrenoceptor stimulation with exogenous norepinephrine or release of endogenous catecholamines mimics ischemic preconditioning.
Topics: Animals; Blood Pressure; Coronary Circulation; Heart Rate; Male; Myocardial Infarction; Myocardial I | 1994 |
Ischemic preconditioning fails to limit infarct size in reserpinized rabbit myocardium. Implication of norepinephrine release in the preconditioning effect.
Topics: Animals; Blood Pressure; Female; Heart Rate; Male; Myocardial Infarction; Myocardial Stunning; Myoca | 1993 |
Adrenergic activation confers cardioprotection mediated by adenosine, but is not required for ischemic preconditioning.
Topics: Adenosine; Adrenergic alpha-Agonists; Animals; Ischemic Preconditioning, Myocardial; Myocardial Infa | 1996 |
Attenuation of S-T segment elevation during repetitive coronary occlusions truly reflects the protection of ischemic preconditioning and is not an epiphenomenon.
Topics: Animals; Coronary Disease; Electrocardiography; Hemodynamics; Injections, Intravenous; Ischemic Prec | 1997 |
Time course and mechanism of myocardial catecholamine release during transient ischemia in vivo.
Topics: Animals; Blood Pressure; Coronary Circulation; Female; Heart; Heart Rate; Male; Microdialysis; Myoca | 2000 |
Studies of the fate of tyramine in dogs: the effect of monoamine oxidase inhibition, portafemoral shunt and coronary artery ligation on the kinetics of tyramine.
Topics: Adult; Animals; Chromatography, Thin Layer; Coronary Vessels; Dogs; Erythrocytes; Female; Femoral Ve | 1977 |
Chronic whole body sympathectomy fails to protect ischemic rabbit hearts.
Topics: Animals; Collateral Circulation; Coronary Circulation; Coronary Disease; Female; Heart Ventricles; H | 1989 |
Functional integrity of sympathetic efferent postganglionic axons in a region of stunned myocardium.
Topics: Animals; Autonomic Fibers, Postganglionic; Axons; Dogs; Efferent Pathways; Electric Stimulation; Fem | 1989 |
Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit.
Topics: Animals; Creatine Kinase; Fibrinolytic Agents; Histamine; In Vitro Techniques; Isoproterenol; Ligati | 1986 |
[Neuro-humoral regulation of anaerobic formation of energy in the ischemic myocardium].
Topics: Animals; Catecholamines; Coronary Disease; Denervation; Dogs; Ethanolamines; Glucosyltransferases; G | 1968 |